DL-Norepinephrine Hydrochloride - CAS 55-27-6
Catalog: |
BB028975 |
Product Name: |
DL-Norepinephrine Hydrochloride |
CAS: |
55-27-6 |
Synonyms: |
4-(2-Amino-1-hydroxyethyl)-1,2-benzenediol; (+/-)-Noradrenaline Hydrochloride; DL-Arterenol Hydrochloride; NSC 7930; dl-Noradrenaline Hydrochloride; dl-Norepinephrine Hydrochloride |
Application: |
Adrenergic alpha-Agonists |
Related CAS: | 138-65-8 (free base)
|
IUPAC Name: | 4-(2-amino-1-hydroxyethyl)benzene-1,2-diol;hydrochloride |
Description: | Norepinephrine is the neurotransmitter at most sympathetic neuroeffector junctions and has pharmacologic activities on both α1 and β1 adrenoceptors. |
Molecular Weight: | 205.64 |
Molecular Formula: | C8H12ClNO3 |
Canonical SMILES: | C1=CC(=C(C=C1C(CN)O)O)O.Cl |
InChI: | InChI=1S/C8H11NO3.ClH/c9-4-8(12)5-1-2-6(10)7(11)3-5;/h1-3,8,10-12H,4,9H2;1H |
InChI Key: | FQTFHMSZCSUVEU-UHFFFAOYSA-N |
Boiling Point: | 442.6 °C at 760 mmHg |
Melting Point: | 142-144 °C |
Purity: | ≥95% |
Density: | 1.397 g/cm3 |
Solubility: | Soluble in DMSO (Slightly), Methanol (Slightly), Water (Slightly, Sonicated) |
Appearance: | White to off-white solid |
Storage: | Store at -20°C under inert atmosphere |
MDL: | MFCD00012880 |
LogP: | 1.59220 |
GHS Hazard Statement: | H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral] |
Precautionary Statement: | P264, P270, P301+P310, P321, P330, P405, and P501 |
Signal Word: | Danger |
Publication Number | Title | Priority Date |
KR-102301781-B1 | Eco-friendly thermal shield and waterproof paint composition having high elasticity and high performance and construction method for thermal shielding and waterproofing using the same | 20210727 |
KR-102265343-B1 | Basalt fiber sheet for repairing and reinforcing concrete structure and repairing and reinforcing method for concrete structure using same | 20210527 |
CN-113045415-A | Synthesis method of noradrenaline impurity | 20210328 |
CN-112263706-A | Biodegradable biological adhesive and preparation method thereof | 20201012 |
CN-112079733-A | Method for asymmetrically synthesizing noradrenaline bitartrate | 20200925 |
PMID | Publication Date | Title | Journal |
21489662 | 20110601 | Facile synthesis, vasorelaxant properties and molecular modeling studies of 2-amino-8a-methoxy-4H-pyrano[3,2-c]pyridine-3-carbonitriles | European journal of medicinal chemistry |
20828883 | 20101101 | Synthesis and vasodilation activity of some novel bis(3-pyridinecarbonitrile) derivatives | European journal of medicinal chemistry |
20615586 | 20100901 | Regioselective synthesis and molecular modeling study of vasorelaxant active 7,9-dioxa-1,2-diaza-spiro[4.5]dec-2-ene-6,10-diones | European journal of medicinal chemistry |
18241958 | 20080901 | Synthesis of new 3-pyridinecarboxylates of potential vasodilation properties | European journal of medicinal chemistry |
17579502 | 20070101 | Cardiovascular alterations after injection of 2% lidocaine with norepinephrine 1:50,000 (xylestesin) in rats | Anesthesia progress |
Complexity: | 142 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 2 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 205.0505709 |
Formal Charge: | 0 |
Heavy Atom Count: | 13 |
Hydrogen Bond Acceptor Count: | 4 |
Hydrogen Bond Donor Count: | 5 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 205.0505709 |
Rotatable Bond Count: | 2 |
Topological Polar Surface Area: | 86.7 Å2 |
Undefined Atom Stereocenter Count: | 1 |
Undefined Bond Stereocenter Count: | 0 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Oxygen Compounds
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS